- Ethics Home Page
- About the Center
- Focus Areas
- Contact Us
- Site Index
Managing Moral Responsibility for Product Use
Does a company bear responsibility for the use to which customers put its products? Gene chip manufacturer Affymetrix faces that question as it considers requests from a variety of companies that may use its micro arrays inappropriately.
SCU Professor of Management Manuel Velasquez worked with Affymetrix Senior Manager of Corporate Affairs Katie Buck to outline the ethical issues the company should consider. Velasquez presented their findings at a recent meeting of the Business and Organizational Ethics Partnership.
Velasquez pointed out that asking if a company is morally responsible is not the same as asking if its actions are right or wrong. Responsibility focuses, instead, on who is to blame, or who should be held accountable, for wrongdoing. The particular focus of the work with Affymetrix is on what a company's moral responsibility is when it knows a customer has used or will use its products to wrongly injure a third party. Is the company responsible for the injuries its customer wrongly inflicts on the third party?
He gave two examples from recent history: I.G. Farben, whose managers knew their product, Zyclon B, was being used in the gas chambers of Auschwitz and other concentration camps; and IBM, whose wholly owned subsidiary, Dehomag, provided the data cards and sorting machines the Nazis used to identify Jews in Germany and occupied countries.
Affymetrix potential clients are not proposing such obviously heinous uses, but customers can use its chips to identify disorders that are racially or ethnically linked or to identify people by race for tracing criminals. Critics argue that such race-based genetics will encourage racism or lead to discrimination by insurers or employers.
Other potential Affymetrix customers want to use the chips for screening that has no scientific validity. For example, some companies purport to analyze people's genetic makeup to offer them personalized diets or supplements whose efficacy is not proven.
In analyzing the ethical issues, Velasquez recommended three basic questions:
- The Dignity of Nature
Kenneth Manaster, SCU School of Law professor, reflects on his decades of work in environmental law
Dec 3, 2015
- 2015 Annual Report
A closer look at the ethical challenges taken on this past year, along with some of the solutions.
- Our Future on a Shared Planet
Cardinal Turkson delivers keynote address at climate conference
- More News »